Clinical characteristics of 17 patients with COVID-19 and systemic autoimmune diseases: a retrospective studyYao Huang, Zhe Chen, Yu Wang, Liang Han, Kai Qin, Wenya Huang, Ying Huang, Hui Wang, Pan Shen, Xin Ba, Weiji Lin, Hui Dong, Mingmin Zhang, Shenghao Tu
14 August 2020
Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseasesJose L Pablos, Lydia Abasolo, Jose M Alvaro-Gracia, Francisco J Blanco, Ricardo Blanco, Isabel Castrejón, David Fernandez-Fernandez, Benjamín Fernandez-Gutierrez, María Galindo-Izquierdo, Miguel A Gonzalez-Gay, Sara Manrique-Arija, Natalia Mena Vázquez, Antonio Mera Varela, Miriam Retuerto, Alvaro Seijas-LopezSee the full list of authors
14 August 2020
Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC studySofia Ramiro, Rémy L M Mostard, César Magro-Checa, Christel M P van Dongen, Tom Dormans, Jacqueline Buijs, Michiel Gronenschild, Martijn D de Kruif, Eric H J van Haren, Tom van Kraaij, Mathie P G Leers, Ralph Peeters, Dennis R Wong, Robert B M Landewé
14 August 2020
Incidence trend of five common musculoskeletal disorders from 1990 to 2017 at the global, regional and national level: results from the global burden of disease study 2017Ziyi Jin, Dandan Wang, Huayong Zhang, Jun Liang, Xuebing Feng, Jinkou Zhao, Lingyun Sun
13 July 2020
Clinical features of rheumatic patients infected with COVID-19 in Wuhan, ChinaCong Ye, Shaozhe Cai, Guifen Shen, Hanxiong Guan, Liling Zhou, Yangyang Hu, Wei Tu, Yu Chen, Yikai Yu, Xuefen Wu, Yuxue Chen, Jixin Zhong, Lingli Dong
13 July 2020
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registryMilena Gianfrancesco, Kimme L Hyrich, Sarah Al-Adely, Loreto Carmona, Maria I Danila, Laure Gossec, Zara Izadi, Lindsay Jacobsohn, Patricia Katz, Saskia Lawson-Tovey, Elsa F Mateus, Stephanie Rush, Gabriela Schmajuk, Julia Simard, Anja StrangfeldSee the full list of authors
14 June 2020
Comparative risk of serious infections among real-world users of biologics for psoriasis or psoriatic arthritisXintong Li, Kathleen M Andersen, Hsien-Yen Chang, Jeffrey R Curtis, G Caleb Alexander
27 January 2020
Tuberculosis in biologic users for rheumatic diseases: results from the South African Biologics Registry (SABIO)Clive Pettipher, Romela Benitha
27 January 2020
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaborationLykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe, Johan Askling, Adrian Ciurea, Herman Mann, Fatos Onen, Eirik Klami Kristianslund, Dan Nordström, Maria Jose Santos, Catalin Codreanu, Juan Gómez-Reino, Ziga Rotar, Bjorn Gudbjornsson, Daniela Di Giuseppe, Michael J NissenSee the full list of authors
15 October 2019
Development and validation of risk stratification trees for incident slow gait speed in persons at high risk for knee osteoarthritisLeena Sharma, Kent Kwoh, Jungwha (Julia) Lee, Jane Cauley, Rebecca Jackson, Marc Hochberg, Alison H Chang, Charles Eaton, Michael Nevitt, Jing Song, Orit Almagor, Joan S Chmiel
12 September 2019